Abstract: In its standard formulation, the control barrier function (CBF) method scales poorly as the order of the system dynamics increases. On the one hand, the need of recursively extending the ...

Abstract: Inthis article, we considered dynamic video transcoding, leveraging Azure Functions’ serverless technology. In the theoretical and analytical part of the article, we explained concepts such ...

Executive functions (EFs) are higher-order cognitive control processes that enable goal-directed behavior, self-regulation, and adaptive functioning across the lifespan. A widely adopted theoretical ...

Serverless is an architectural style that succeeds only when paired with intentional design patterns. Event-driven approaches often provide simpler, more resilient solutions than overused ...

The pace of innovation in cloud computing continues unabated, with AWS recently unveiling durable functions for AWS Lambda. This move could have significant implications for how enterprises design and ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...

Microsoft introduces unique hostnames for Azure Functions and Logic Apps, reducing endpoint security risks. Non-enumerable Azure app URLs limit reconnaissance, scanning, targeted attacks and dangling ...

Cloud security architect and advisor Steven Smiley walked attendees through a slate of notable AWS announcements in a Virtualization & Cloud Review webcast today. The presentation held by Smiley, an ...

I am a Backend Developer and Software Engineer with a solid background in Artificial Intelligence in academic and professional fields, looking forwa ...

Week 16 follow-up data, coupled with blinded exit interviews conducted up to 364 days after the study period, confirm durable and wide-ranging upper and lower-body improvements compared to placebo ...

Nes-Ziona, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. ( Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced positive ...